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Type I interferon (IFN) is an important host defense
cytokine against intracellular pathogens, mainly
viruses. In assessing IFN production in response to
group B streptococcus (GBS), we find that IFN-b
wasproducedbymacrophagesuponstimulationwith
both heat-killed and live GBS. Exposure of macro-
phages to heat-killed GBS activated a Toll-like
receptor (TLR)-dependent pathway, whereas live
GBS activated a TLR/NOD/RIG-like receptor (RLR)-
independent pathway. This latter pathway required
bacterial phagocytosis, proteolytic bacterial degra-
dation, and phagolysosomal membrane destruction
by GBS pore-forming toxins, leading to the release
of bacterial DNA into the cytosol. GBS DNA in the
cytosol induced IFN-b production via a pathway
dependent on the activation of the serine-threonine
kinase TBK1 and phosphorylation of the transcription
factor IRF3. Thus, activation of IFN-a/-b production
during infection with GBS, commonly considered an
extracellular pathogen, appears to result from the
interaction of GBS DNA with a putative intracellular
DNA sensor or receptor.
INTRODUCTION
Interferons (IFNs) are multifunctional cytokines important in host
defense, particularly against intracellular pathogens. Type I IFNs
have long been acclaimed for their role in antiviral host defense;
however, an expanding body of work shows that type I IFNs are
likewise important in the host response to bacterial infection
(Henry et al., 2007; Pitha, 2004). Their activity can influence
numerous immune-effector mechanisms, exerting effects that
can be either favorable or detrimental to the host upon bacterial
infection (Hein et al., 2000; O’Connell et al., 2004; O’Riordan
et al., 2002; Opitz et al., 2006; Stanley et al., 2007).
Conserved bacterial products have been found to activate
distinct signal transduction pathways that merge with pathwaysCell Hostactivated by viruses and lead to type I IFN production. Indeed,
the type I IFN response resulting from Gram-negative bacterial
infections, such as those caused by Salmonella typhimurium
and Escherichia coli, seems to be triggered, at least partially,
by lipopolysaccharide (LPS) through the Toll-like receptor 4
(TLR4)/MD-2 signaling complex (Sing et al., 2000; Yaegashi
et al., 1995). Another bacterial component that might induce
type I IFN is Gram-negative flagellin, although contradictory
studies have been published (Mizel et al., 2003; Opitz et al.,
2006; Simon and Samuel, 2007).
The most extensive studies of the role of type I IFNs in bacterial
infection have focused on the pathways activated by intracellular
pathogens (O’Connell et al., 2005; Reimer et al., 2007; Stetson
and Medzhitov, 2006; Stockinger et al., 2004). Several studies
have suggested that IFN-inducing ligands detected upon
cytosolic invasion are found in numerous intracellular patho-
gens. For example, the invasive Shigella flexneri, Legionella
pneumophila, or Francisella tularensis activate a potent IFN-
a/-b response in fibroblasts and macrophages, whereas their
respective noninvasive strains do not (Henry et al., 2007; Hess
et al., 1987, 1990; Opitz et al., 2007). Similarly, Trypanosoma
cruzi, a protozoan parasite, activates IFN-a/-b production with
kinetics similar to its escape from the lysosome (Koga et al.,
2006; Vaena de Avalos et al., 2002). The TBK1/IRF3 axis appears
to play a central role in the transcriptional regulation of IFN-b
upon intracellular bacterial infection, but little is known regarding
the bacterial ligands and receptors that function upstream of
TBK1. Upon infection with the cytosolic Gram-positive bacteria
Listeriamonocytogenes,Stetson and Medzhitov have suggested
that the type I IFN response might result from the binding of pro-
karyotic DNA to a cytosolic receptor (Stetson and Medzhitov,
2006). Moreover, it has recently been suggested that the cyto-
solic DNA-dependent activator of IFN-regulatory factors (IRFs),
or DAI, is a bacterial DNA receptor acting as the first step in the
type I IFN pathway activated by intracellular bacteria (Takaoka
et al., 2007). Together, these studies indicate that a common fea-
ture may unite the IFN-a/-b responses to intracellular pathogens,
and that products unique to bacteria are unlikely to be responsi-
ble for activating type I IFNs.
Until recently, extracellular Gram-positive bacteria were be-
lieved to be unable to activate type I IFN gene transcription.& Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc. 543
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Gram-positive bacteria such as Streptococcus agalactiae (group
B streptococcus [GBS]) and Streptococcus pneumoniae were
also able to induce type I IFN, and that this IFN production was
critical for the clearance of infection by the host. Indeed, mice
lacking either IFN-a/-b receptor (IFNAR) or IFN-b displayed an
unrestrained bacteremia (Mancuso et al., 2007).
Here, we have studied and characterized the pathway lead-
ing to type I IFN production in mouse macrophages infected
with the extracellular bacterium GBS, a species found in the
normal flora of the gut and the female urogenital tract (Schu-
chat, 1999). Early perinatal infection with GBS causes pneumo-
nia and/or septicemia—both associated with high mortality
rates. In this report, we provide evidence that in addition to in-
ducing a very potent inflammatory response, requiring TLR rec-
ognition, GBS induces a type I IFN response. This response
was both TLR-dependent and TLR/NOD/retinoic-acid-inducible
gene (RIG)-like receptor (RLR)-independent, depending on
whether live or killed bacteria were tested. Live bacteria, in par-
ticular, seem to activate type I IFN production via TBK1-medi-
ated phosphorylation of IRF3—a process that is associated
with the release of bacterial products, especially DNA, from the
phagolysosome. We observed the initiation of an autocrine loop
in which GBS induces the production of important IFN-induc-
ible genes such as that encoding viperin. Since type I IFNs
play such a critical role in the outcome of serious GBS infec-
tion, these findings underscore the potentially important con-
tributions of phagolysosomal escape in the initiation of host
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Figure 1. Live and Heat-Killed GBS Organ-
isms Induce Type I IFNs and Proinflamma-
tory Cytokines
(A–C) WT bone marrow-derived macrophages
(BMDMs) were stimulated for the indicated
amount of time with heat-killed GBS (HK GBS;
80 mg/ml) or live GBS (MOI 6:1). Levels of mRNA
for TNF-a (A), IFN-b (B), and viperin (C) were deter-
mined by Q-PCR and normalized to HPRT1 level
of expression.
(D) WT BMDMs were stimulated for 12 hr with
two-fold decreasing amounts of bacteria; the ini-
tial concentration of heat-killed GBS (HK GBS;
80 mg/ml), live GBS (MOI 10:1) and Sendai virus
(150 HAU/ml). IFN-b was detected by ELISA.
*, P < 0.05, Student’s t test (all panels).
defenses and in the pathology that de-
velops during GBS infection.
RESULTS
Live and Heat-Killed GBS Induce
Type I IFN Production
We studied the response of C57BL/6
bone marrow-derived macrophages
(BMDMs) stimulated with live and heat-
killed GBS. As anticipated, both live and
heat-killed forms of GBS evoked a
very strong inflammatory response
(Figure 1A). In addition, both live and heat-killed GBS induced
type I IFN induction (Figure 1B). Induction of IFN-b peaked at
2 hr postinfection with heat-killed GBS and 6 hr postinfection
with live GBS: the latter response was delayed compared with
that induced by live intracellular bacteria such as Listeria mono-
cytogenes (peak induction at 3–4 hr) (Stockinger et al., 2004;
data not shown). A highly IFN-inducible gene, viperin (virus-inhib-
itory protein, endoplasmic reticulum-associated, IFN-inducible)
(Severa et al., 2006), displayed a similar kinetic as IFN-b (Fig-
ure 1C). The induction of viperin upon GBS infection was entirely
dependent on IFN-a/-b and did not occur in macrophages defi-
cient in the type I IFN-a/-b receptor (Figure S1). At the protein
level, live GBS infection induced similar amounts of IFN-b to
that observed upon Sendai virus infection, whereas macro-
phages stimulated with heat-killed GBS produced no
detectable IFN-b (Figure 1D).
Live and Heat-Killed GBS Activate Distinct Pathways
Leading to Type I IFN Production
GBS is a potent activator of the innate immune system. Along
with other investigators, we have reported that GBS presents
multiple TLR ligands to innate immune cells (Cusumano et al.,
2004; Henneke et al., 2001; Mancuso et al., 2004). Thus, we an-
ticipated that the induction of type I IFN would be dependent on
TLRs, which appear to recognize ligands that are located either
extracellularly (e.g., LPS [Poltorak et al., 1998]) or within a lyso-
somal compartment (e.g., CpG DNA [Hemmi et al., 2000]). The
TLR family of receptors uses four adaptor molecules: Mal/TIRAP,544 Cell Host & Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc.
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Type I IFN Induced by DNA from an Extracellular PathogenMyD88, Toll/IL-1 receptor (TIR)-domain-containing adaptor in-
ducing IFN-b (TRIF), and TRIF-related adaptor molecule (TRAM)
(Akira and Sato, 2003). For most of the TLRs, MyD88 is the only
critical adaptor; however, TLR3 signaling relies on the TRIF adap-
tor exclusively (Yamamoto et al., 2003). Furthermore, where more
than one adaptor is involved, Mal/TIRAP and TRAM function as
bridging adapters upstream of MyD88 and TRIF, respectively
(Kagan and Medzhitov, 2006; Rowe et al., 2006). Hence, MyD88
and TRIF double-knockout mice are thought to be unable to
signal via TLRs. To analyze the contributions of TLRs to the in-
duction of the type I IFN response to GBS, we used MyD88/
TRIF double-knockout macrophages. The heat-killed form of
GBS required MyD88 and/or TRIF for induction of type I IFN
(Figure 2A). In striking contrast, TLRs were not required for
induction of the type I IFN response during live GBS infection.
Indeed, upon stimulation with live GBS, the induction of the
IFN response was higher in macrophages lacking both MyD88
and TRIF compared to WT cells (Figure 2A). This increase in
IFN-b induction in the MyD88/TRIF double-knockout cells sug-
gests a role for a negative regulator of the type I IFN response
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Figure 2. Live and Heat-Killed GBS Bacteria Activate
Distinct Pathways Leading to Type I IFNs Production
(A–C) WT and MyD88/TRIF-deficient BMDM were stimulated
as in Figure 1 for 6 hr and the amount of IFN-b (A) and TNF-a
(C) mRNA determined by Q-PCR and were normalized to
HPRT1 level of expression. (B) Phosphorylation of the tran-
scription factor STAT2 in WT or MyD88/TRIF-deficient
BMDMs was compared after 2 hr infection with live GBS
(MOI 10:1). *, P < 0.05, Student’s t test.
(D) WT and RIP2-deficient BMDMs were stimulated as men-
tioned above and the amount of IFN-b mRNA determined.
downstream of MyD88 or TRIF. Phosphorylation
of STAT2, a necessary step in the formation of the
ISGF-3 complex downstream of the IFN-a/-b
receptor, also followed a similar profile in
MyD88/TRIF double-deficient macrophages (Fig-
ure 2B). In contrast, the induction of proinflam-
matory cytokines such as tumor necrosis factor
a (TNF-a) was entirely dependent on MyD88/
TRIF in studies using both killed and live bacteria
(Figure 2C).
The NOD-like receptors (NLRs) are critical sen-
sors of a variety of bacterial and nonbacterial
mediators of inflammation, consisting of the NOD
proteins and a large group of NALP proteins that
regulate the proteolytic cleavage of IL1b (Kanne-
ganti et al., 2007). NOD1 and NOD2 are well-
established receptors for bacterial peptidoglycan
(Chamaillard et al., 2003; Girardin et al., 2003;
Inohara et al., 2005). NOD receptors can partici-
pate in the recognition of heat-killed bacteria lead-
ing to the induction of type I IFN (Herskovits et al.,
2007). However, in receptor-interacting protein 2
(RIP2) knockout macrophages, which lack NOD1
and NOD2 signaling, both heat-killed and live
GBS activated a potent IFN-b response (Fig-
ure 2D). We conclude from these experiments
that GBS has the capacity to induce type I IFNs via a TLR-depen-
dent and a TLR/NOD-independent manner.
Uptake and Degradation of Live GBS Are Required
for the Induction of the Type I IFN Response
All previously described bacteria activating the type I IFN path-
way independently of TLRs are found in the cytosol (e.g., Listeria
monocytogenes) or require a secretion system (e.g., Legionella
pneumophila) (Opitz et al., 2006; Stetson and Medzhitov,
2006). Indeed, all the receptors identified as critical in the recog-
nition of intracellular pathogens have been localized in the cyto-
plasm. GBS, an extracellular organism, is known to invade some
specific cell types, including human brain microvascular endo-
thelial cells and respiratory epithelial cells (Baron et al., 2004;
Gibson et al., 1993, 1995; Rubens et al., 1992; Shin et al.,
2006). Moreover, additional studies have documented the ability
of GBS to enter macrophages by phagocytosis and to survive in-
side the phagocytic vacuole for up to 48 hr (Cornacchione et al.,
1998; Valenti-Weigand et al., 1996). Nevertheless, the cytosolic
invasion of macrophages by GBS has not been describedCell Host & Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc. 545
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ism to release material into the host cytosol has been identified.
We investigated whether live GBS activated a membrane-
bound receptor, or whether bacterial uptake was required for
activation of the type I IFN pathway. Pretreatment of WT macro-
phages with cytochalasin D (Figure 3), an inhibitor of actin
polymerization, inhibited activation of the pathway leading to
IFN-b production. An important observation was that cytochala-
sin D had no effect on IFN induction by Sendai virus, which
signals via the RIG-I pathway. These results suggested that the
uptake of GBS is required for the binding of GBS-derived mole-
cules to an intracellular receptor. Electron and confocal micros-
copy allowed us to visualize the entry of GBS through the phago-
cytic pathway (Figure 4). The great majority of the GBS cells
appeared to be surrounded by a membrane (Figure 4A) colocal-
izing with the phagosomal marker Lamp1 (Figure 4D, top).
Nevertheless, a small percentage of bacteria (less than 1%)
were found consistently without a surrounding membrane (Fig-
ures 4B and 4C) and were not colocalized with Lamp1 (Fig-
ure 4D). The intracellular localization of these bacterial cells
was seen by staining the mammalian membrane with fluorescent
cholera toxin b.
Puzzled by this finding, we wondered whether known pore-
forming toxins of GBS, namely hemolysin and CAMP factor,
were responsible for the escape of GBS or GBS cell fragments
from the phagolysosome, as has been shown for lysteriolysin
from L. monocytogenes (Berche et al., 1988). Thus, we investi-
gated the ability of GBS knockouts in hemolysin, CAMP factor,
or double-knockout strains to trigger the IFN responses. We
found that hemolysin plays a critical role in the induction of
type I IFN (Figure 4E). Similarly, the absence of the CAMP factor
toxin was associated with a reduction in the type I IFN response
(Figure 4E). This result suggested that hemolysin and CAMP
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Figure 3. Phagocytosis of Live GBS Is Required for the Release of
the IFN-Inducing Material
WT BMDMs were pretreated for 30 min with cytochalasin D (2 mM) before
being infected with live GBS (MOI 6:1) for 6 hr or Sendai virus (150 HAU/ml)
for 4 hr and IFN-b mRNA measured as in Figure 1. *, P < 0.05, Student’s t test.546 Cell Host & Microbe 4, 543–554, December 11, 2008 ª2008 Elsfactor form pores in the phagosomal membrane that allow the
escape of GBS or of GBS material into the host cytosol, leading
to the upregulation of the type I IFN. These two toxins did not
appear to play a role in the upregulation of the proinflammatory
response, since the production of TNF-a was unaffected
by GBS lacking hemolysin and/or CAMP factor with WT GBS
(Figure S2).
Pretreatment of cells with bafilomycin A1 (Figure 5A), a potent
and specific inhibitor of the vacuolar H+ ATPase (V-ATPase), or
with chymostatin (Figure 5B), a strong inhibitor of lysosomal
serine and cysteine proteinases, abolished type I IFN induction
by live GBS in WT macrophages. Neither bafilomycin A1 nor chy-
mostatin pretreatment had any effect on Sendai virus responses.
Bafilomycin A1 modifies the phagosomal pH and alters the for-
mation of phagolysosomes, while chymostatin treatment results
in the inhibition of chymotrypsin, chymases, and lysosomal en-
zymes such as cathepsin B, H, and L. The ability of both drugs
to abolish IFN induction highlighted the essential role of bacterial
degradation in phagolysosomes as a key event in the induction
of the type I IFN response.
In conclusion, these experiments suggest that the type I IFN
response observed during live GBS infection requires the phago-
cytosis of GBS followed by the alteration of the phagolysosomal
membrane by pore-forming toxins leading to the release into
the cytosol of bacterial degradation products. The identification
of whole GBS outside of the phagolysosome is a physical
manifestation of the loss of integrity of this compartment during
infection.
Characterization of the Pathway Activated During Live
GBS Infection
To date, the pathways that regulate the type I IFN response inde-
pendently of TLRs employ the TBK1-IRF3 axis. We therefore
examined the role of TBK1 and IRF3 in live GBS-induced IFN
responses. Although TBK1 deficiency is embryonic lethal, this
lethality is reversed when TBK1-deficient mice are crossed
with TNFR1-deficient mice. We next compared TNFR1 and
TBK1/TNFR1-deficient macrophages for GBS-induced IFN
responses. TBK1/TNFR1-deficient macrophages had a strongly
reduced IFN response upon challenge with GBS (Figure 6A).
Macrophages deficient in the related kinase IKK-3 showed
a weak but consistent decrease in IFN-b induction (Figure S3).
This partial effect is probably due to the redundancy of IKK-3
and TBK1 kinases in the regulation of type I IFN production in
macrophages. Consistent with a role for the IKK-related kinases
in GBS-induced IFN responses, IRF3-deficient macrophages
had a marked defect in IFN-b induction in response to GBS
(Figure 6B, left panel). Likewise, phosphorylation of STAT2 was
strongly reduced in IRF3-deficient macrophages compared
with WT macrophages upon GBS infection (Figure 6B, right
panel). Taken together, these data suggest that the pathway
triggered by GBS infection involves TBK1 and IRF3.
Upstream of the TBK1/IRF3 axis, several classes of pattern
recognition receptors (PRRs) have been identified in addition
to the TLRs. These include the RLRs and a cytosolic sensor of
DNA: DAI. RLRs such as RIG-I (Yoneyama et al., 2004) and mel-
anoma differentiation-associated gene-5 (MDA5) (Kato et al.,
2006), discriminate between different classes of RNA viruses,
while DAI detects synthetic DNA delivered to the cytosol withevier Inc.
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dent pathways converge at the IKK-related kinases, TBK1 and
IKK-3, which phosphorylate and activate IRF3 and IRF7. In the
case of the RLRs, a mitochondrial localized adaptor molecule,
MAVS (mitochondrial antiviral signaling, also called IPS-1,
CARDif, or VISA), relays signals from the RLRs to TBK1. MAVS-
deficient macrophages fail to produce IFN in response to ligands
or viruses that signal via RIG-I and MDA5 (Kawai et al., 2005).
MAVS-deficient macrophages responded normally to GBS but
were severely compromised in their ability to respond to Sendai
virus (Figure 6C). These observations suggest that live GBS is not
recognized by either RIG-I or MDA-5.
To determine whether DAI is involved, we generated short
hairpin RNA (shRNA) targeting constructs that blocked expres-
sion of DAI in macrophages and murine embryonic fibroblasts
(MEF) (Figure 6D). In the absence of DAI expression, GBS trig-
gered the IFN-b response normally. Taniguchi et al. have shown
recently that overexpression of DAI can enhance dsDNA-in-
duced IFN responses. Overexpression of DAI in immortalized
murine macrophages or in MEFs did not result in increased pro-
duction of type I IFN in response to GBS infection (Figure S4).
Collectively, these data suggest that GBS-induced IFN does
not involve either the RLRs or DAI.
Cytosolic DNA Is an IFN-Activating Ligand of GBS
Studies with L. monocytogenes have shown that delivery of bac-
terial DNA to the cytoplasm activates the type I IFN pathway
(Stetson and Medzhitov, 2006). We performed similar experi-
ments with GBS. Extracts from sonicated GBS were prepared
and tested for their ability to trigger IFN responses. Consistent
with our findings with live GBS, extracts of GBS transfected
into cells induced IFN production via a pathway that was depen-
dent on TBK1 and IRF3 but independent of TLRs (Figure 7A).
Treatment of GBS extract with DNase I—but not RNase A—abol-
ished this stimulatory activity, a result suggesting that DNA is
likely to be the ligand responsible for triggering the IFN response
(Figure 7B). RNase H is a ribonuclease that cleaves the 30-O-P-
bond of RNA in an RNA/DNA duplex to produce 30-hydroxyl-
and 50-phosphate-terminated products, releasing newly acces-
sible DNA molecules. RNase H treatment enhanced IFN
response to GBS, further implicating GBS DNA as the ligand
responsible for the observed IFN response. From these
experiments, we can conclude that the only IFN-inducing ligand
found in the intracellular content of GBS activating a cytoplasmic
receptor is GBS DNA. Furthermore, we tagged GBS DNA using
the cell-permeant Syto 60 red fluorescent nucleic acid stain in
live GBS and followed the localization of GBS DNA upon phago-
cytosis and degradation of the bacteria by confocal microscopy.
Using this approach, we observed GBS DNA outside of Lamp1-
positive compartments in macrophages that underwent phago-
cytosis of bacteria (Figure 7Ca). In contrast, we could not ob-
serve GBS DNA outside of the Lamp1-positive compartments
in macrophages infected with the hemolysin-deficient strain
(Figure 7Cb), or within macrophages infected with WT GBS
and pretreated with bafilomycin A1 (Figure 7Cc) or chymostatin
(Figure 7Cd).
To exclude a role for TLR9 in GBS-DNA recognition, we also
tested macrophages lacking TLR9 for their ability to trigger IFN
responses. Consistent with our studies in MyD88/TRIF-deficientCell Hostmacrophages, the activation of the type I IFN pathway by GBS
DNA did not require TLR9 (Figure S5A). Furthermore, chloro-
quine, used at concentrations that block TLR9 signaling, had
no effect on the ability of live GBS to induce IFN-b (Figure S5B).
These data suggest that GBS induces IFN via TBK1/IRF3, and
that triggering of this pathway in all likelihood involves a cytosolic
DNA-sensing pathway that is not DAI.
DISCUSSION
The type I IFN response is critical in host defense against GBS
(Mancuso et al., 2007). Mice unable to mount a type I IFN
response are hypersusceptible to lethality induced by GBS,
with a mortality rate surpassing that seen in the absence of
IFN-g signaling, a well-established mediator of host defenses
against bacteria (Schroder et al., 2004). The inability of IFN-
a/-bR-deficient mice to control GBS infection was partially
accounted for by defective IFN-b signaling, however, a role for
IFN-a and/or -u subtypes is also a possibility.
Initially, TLR4 was thought to be the sole bacterial recognition
receptor leading to type I IFN induction. Gram-positive bacteria
were initially believed to be sensed entirely by TLR2 (Takeuchi
et al., 1999; Yoshimura et al., 1999), which does not induce an
IFN response. Several families of germline-encoded PRRs dis-
tributed in different subcellular compartments have since been
identified, including the complement system in the extracellular
environment, the TLRs and dectin-1 on the plasma membrane,
TLRs in the endosomal compartment, and finally RLRs, NLRs,
and DAI in the cytosol. In our study, we have examined the role of
many of these sensors in regulating the IFN-b response to GBS.
We have shown that, upon GBS infection, the induction of the
type I IFN-b response proceeds via a pathway dependent on
TBK1 and IRF3, a pathway activated by many pathogens. How-
ever, unlike many other pathogens, the GBS-induced type I IFN
response appears to be independent of all currently known me-
diators of the IFN pathway. This TLR/NOD/RLR-independent
pathway is, to the best of our knowledge, unique for a bacterium
that does not have an intracellular lifestyle like Listeria monocy-
togenes, although further studies may establish that other bacte-
ria are capable of activating this response through similar mech-
anisms. GBS is able to survive inside some types of
macrophages for extended periods, but this has never been as-
sociated with enhanced virulence, an ability to replicate intracel-
lularly, or escape from the phagosomal compartment. Neverthe-
less, our study demonstrates that live GBS can be found in the
cytosol and provides evidence that various bacterial products,
such as DNA, escape the phagolysosomal compartment. The
translocation of whole bacteria and bacterial products appears
to be due to the degradation of the phagosomal membrane by
secreted GBS toxins, which form pores in the membrane,
thereby enabling the release of microbial components outside
of the phagosomal compartment.
The multitude of PRRs in the cytosol highlights how active this
environment is in terms of immune surveillance, not only for
viruses, but also for other pathogens. Our findings are consistent
with the hypothesis that an as yet unidentified PRR exists in the
cytosol, poised to respond to GBS infection. We believe that
GBS DNA is responsible for triggering this IFN response, similar
to that postulated for sensing of Listeria monocytogenes (Leber& Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc. 547
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Type I IFN Induced by DNA from an Extracellular Pathogenet al., 2008; Stetson and Medzhitov, 2006). Several PRRs have
been identified as sensors for both microbial as well as self
DNA. These include TLR9 in the endosome and DAI or NALP3
(Muruve et al., 2008) in the cytosol. Both TLR9 and DAI have
been implicated in IFN responses to other pathogens; however,
our studies clearly demonstrate that neither TLR9 nor DAI are re-
sponsible for IFN induction in response to GBS.
DNA from GBS found in the cytosol could originate as a result
of bacteria being degraded in the phagolysosome. Since the
sensor for Listeria monocytogenes also remains unknown at
this point, it is possible that the same molecule(s) could sense
both organisms. Should this be the case, it would be of interest
to understand why the IFN response is protective in the case of
GBS, yet detrimental in the case of Listeria, despite the similari-
ties in the sensing and signaling pathways engaged by both
organisms. One partial explanation might be the difference in
the amplitude of the type I IFN response upon infection with ex-
tracellular or intracellular organisms. Indeed, recent work from
Leber and colleagues demonstrated that in the case of Listeria
infection, NOD2 signaling appears to cooperate with the cyto-
solic DNA-sensing pathway for optimal triggering of the cytosolic
IFN responses (Leber et al., 2008). In our study, however, we
found no evidence that NOD2 plays such a role, since macro-
phages lacking RIP2, the downstream transducer of the NOD2
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Figure 5. Degradation of the Bacteria Is Re-
quired for the Release of the IFN-Inducing
Ligand
(A and B) WT BMDMs were pretreated for 30 min
with bafilomycin A1 (200 nM) (A) or chymostatin
(100 mM) (B) before being infected with live GBS
(MOI 6:1) for 6 hr or Sendai virus (150 HAU/ml)
for 4 hr. The amount of IFN-b mRNA was deter-
mined by Q-PCR. *, P < 0.05, Student’s t test.
pathway, were not compromised in their
ability to trigger IFN production upon
GBS infection. As a consequence, the
amplitude of the GBS response was
lower than that triggered by Listeria.
GBS is a life-threatening infection in
newborns and a common cause of
disease in pregnant women, the elderly,
and the immunocompromised. Given
the importance of the type I IFN response
in protecting the host against GBS, it is
clear that understanding the molecular
mechanisms responsible for triggering the IFN-b as well as
IFN-a and -u responses has both clinical and therapeutic poten-
tial, particularly in terms of vaccine development.
EXPERIMENTAL PROCEDURES
Reagents
Unless otherwise stated, reagents were purchased from Sigma-Aldrich
(St. Louis, MO).
Statistical Analysis
All experiments were performed at least three times. One representative
experiment is shown with each data point derived from a triplicate determi-
nant. Error bars represent SD from a representative experiment. *, p < 0.05,
Student’s t test.
Bacterial Strains
Streptococcus agalactiae strain 515 (type Ia) and NEM 316 (type III) were ob-
tained from the blood of a neonate with sepsis as described previously (Eads
et al., 1982; Glaser et al., 2002). The acapsular form of strain 515 (515DcspE)
was used all throughout these studies unless otherwise stated (Cieslewicz
et al., 2001). In-frame deletion of cfb in NEM316 and NEM316DcylE were
constructed by using splicing-by-overlap-extension PCR with primers O1
(GTATGGGAATTCGGCATAATGGAACGATTT), O2 (GGCACGCCCGGGTGCT
GCCGCTGCACCAGCCACTAGAGTTCC), O3 (GCGGCAGCACCCGGGCGTG
CCCAAGCAGCACTTCAAACAGCA), and O4 (ACTTCTGGATCCCCTCTCCAC
GCTTCTGT). To carry out chromosomal gene inactivation, PCR fragmentsFigure 4. A Small Proportion of Live GBS Bacteria Escapes the Phagosome and Reaches the Cytosol upon Phagosomal Membranes
Degradation
(A–C) Electron microscopy of WT BMDMs infected for 2 hr with GBS. Most GBS organisms were found in the phagosome (A), but a few were observed escaping
the phagosome (B), and some were ultimately identified in the cytosol (C). The black arrow shows the phagosomal membrane, whereas the white arrow highlights
the absence of phagosomal membranes. The magnification is 39,0003.
(D) Confocal microscopy of WT BMDMs infected with live GBS (MOI 10:1) for 2 hr. The phagosomal membrane is stained with Lamp1 (red) and the surface of the
bacteria with an anti-Group B antigen antibody (green). The white arrow shows bacteria located outside the Lamp1-stained membrane. In the lower panel, the
plasma and phagosomal membranes were also stained with cholera toxin b (blue). Phagocytosed bacteria were found in the phagosomal compartment (A) and
outside of this compartment but within the confines of the plasma membrane (B).
(E) WT C57BL/6 BMDMs were stimulated for 6 hr with live GBS: NEM 316 (MOI 7:1), NEM DcylE (MOI 7:1), NEM Dcfb (MOI 6:1), and NEM DcylEDcfb (MOI 7:1).
Levels of mRNA for IFN-b were determined as mentioned in Figure 1. *, P < 0.05, Student’s t test.Cell Host & Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc. 549
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Type I IFN Induced by DNA from an Extracellular Pathogen(O1-O2::O3-O4) were cloned into the thermosensitive shuttle plasmid
pG+host1, and chromosomal gene exchanges were carried out as described
previously (Dramsi et al., 2006). All strains were grown on 5% sheep blood agar
plates overnight at 37C (Remel; Lenexa, KS). Bacterial colonies were re-
moved from the plates after overnight culture, used to inoculate Todd Hewitt
Broth (THB) prepared from endotoxin-free water, and grown overnight without
agitation at 37C. The next morning, the culture was diluted in THB and grown
to mid-logarithmic phase (OD650 = 0.5). After two washes in PBS, GBS was
used to stimulate macrophages. Heat-killed GBS was prepared from
515DcspE strain, which was grown to an OD600 of 0.5; the bacteria were
spun down, resuspended in PBS, and heated at 80C for 1 hr. The bacteria
were then lyophilized and weighed.
GBS DNA Staining
Bacteria were prepared as described above, grown to mid-logarithmic phase
(OD650 = 0.5), and stained for 30 min at room temperature with Syto 60 red fluo-
rescent nucleic acid stain (15 mM in PBS) (Invitrogen; Carlsbad, CA). Macro-
phages seeded at a confluency of 50%–70% were fed Syto60 incorporated
bacteria at a ratio of 20:1. Two hours after infection, the macrophages were
washed extensively and then fixed in 4% paraformadehyde.
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Figure 6. TBK1 and IRF3 Are Critical Com-
ponents of the Pathway Activated by Live
GBS
(A and B) TNFR1/- and TNFR1/TBK1- deficient
BMDMs (A) and C57BL/6 and IRF3/ BMDMs
(B) were stimulated with live GBS (MOI 6:1) for
6 hr or Sendai virus (150 HAU/ml) for 4 hr, and
IFN-b mRNA was measured as mentioned in
Figure 1. In (B), phosphorylation of the transcrip-
tion factor STAT2 was examined in WT and
IRF3-deficient macrophages infected with live
GBS.
(C and D) In (C), C57BL/6 and MAVS-deficient
BMDMs were infected with Sendai virus or GBS
as mentioned above, and IFN-b was measured by
Q-PCR. In (D), C57BL/6 BMDMs were infected
with a retroviral vector encoding shRNA for DAI
and DAI levels measured by Q-PCR before and
after IFN-b treatment (250 U/ml) (left). On the right,
cells infected with DAI shRNA under the same
conditions were exposed to PBS or live GBS
(MOI 1:6) for 6 hr, and IFN-b levels were measured
by Q-PCR. *, P < 0.05, Student’s t test.
Mice
C57BL/6 mice (5- to 6-weeks old) were purchased
from the Jackson Laboratory (Bar Harbor,
ME). MyD88/, TRIF/, and TLR9/ mice
were provided by S. Akira (Osaka University;
Osaka, Japan) and backcrossed onto a C57BL/6
background for at least 12 generations. MyD88/
TRIF/ double-knockout mice were bred from
MyD88/ and TRIF/ mice. IRF3/ mice were
a gift from T. Taniguchi (University of Tokyo;
Tokyo, Japan). IFN-a/-bR/ mice on a C57BL/6
background were a gift from J. Sprent (Scripps
Research Institute; San Diego, CA). IKK-3/
mice were generated at Millennium Pharmaceuti-
cal (Cambridge, MA). TBK1/ mice were a gift
from W.C. Yeh (University of Toronto; Toronto,
ON, Canada) and were bred with TNFR1/mice at
the University of Massachusetts Medical School.
RIP2/ mice were from V. Dixit (Genentech; San
Fransisco, CA). MAVS/ mice were a kind gift of Z.J. Chen (UT Southwestern
Medical School; Dallas, TX). All experiments were conducted with Institutional
Animal Care and Use Committee approval.
Cell Culture
BMDMs were generated as described previously (Fitzgerald et al., 2003), and
their differentiation state was confirmed by staining for F4/80 (Caltag; Burlin-
game, CA) and CD11b (PharMingen; Mississauga, ON, Canada). All cells
were cultured at 37C in 5% CO2 in air in DMEM (CellGro; Herndon, VA) con-
taining L-glutamine (CellGro; Herndon, VA), supplemented with 10% (vol/vol)
FBS (HyClone Laboratories; Logan, UT) and ciprofloxacin (10 mg/ml) (Bayer;
West Haven, CT). PBS was obtained from CellGro. When stimulated with
live GBS, the macrophages were maintained in antibiotic-free DMEM for the
first hour of infection. Ciprofloxacin was later added to the macrophages in-
fected with GBS.
ELISA
Cell culture supernatants were assayed for IFN-b by ELISA (PBL IFN source;
Piscataway, NJ) according to the manufacturer’s instructions.550 Cell Host & Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc.
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Type I IFN Induced by DNA from an Extracellular PathogenQuantitative Real-Time PCR
RNA from murine BMDMs was extracted with an RNeasy kit (QIAGEN, Inc.;
Valencia, CA) according to the manufacturer’s instructions. cDNA was synthe-
sized with the iScript cDNA Synthesis Kit (Biorad; Hercules, CA), and quantita-
tive RT-PCR analysis was performed on a DNA Engine Opticon 2 cycler (MJ
Research; Watertown, MA) with the iQ SYBR Green Supermix (Biorad; Hercu-
les, CA). The specificity of amplification was assessed for each sample by
melting curve analysis. Relative quantification was performed by mean of stan-
dard curve analysis. The murine quantifications data are presented as a ratio
to the hypoxanthine phosphoribosyltransferase 1 (HPRT1) level. The standard
errors (95% confidence limits) were calculated with Student’s t test. All gene
expression data are presented as a ratio of gene copy number per 100 copies
of HPRT1 (as indicated) ± SD. The following primers for detection of IFN-b,
TNF-a, viperin, and HPRT1 mRNAs were designed: vig1, 5-AACCCCCGTGAG
Figure 7. Induction of Type I IFNs by GBS DNA Has the Same Pathway Requirements as Induction by Live GBS
(A) GBS extract was transfected with lipofectamine into WT, IRF3-deficient, or TBK1-deficient BMDMs. *, P < 0.05, Student’s t test.
(B) GBS extract was pretreated with vehicle, DNase I, RNase A, or RNase H and transfected into the cytosol of WT BMDMs, and IFN-b measured by Q-PCR.
*, P < 0.05, Student’s t test.
(C) Confocal microscopy of WT macrophages fed DNA-tagged live GBS (MOI 20:1) for 2 hr. GBS DNA was stained with syto60 dye (red), the phagosomal
membrane with Lamp1 (green), and the plasma membrane with Cholera toxin b (blue). Untreated macrophages were fed WT (a) or hemolysin-deficient (b)
NEM strain. Macrophages were treated with bafilomycin A1 (200 nM) (c) or chymostatin (100 mM) (d). The red arrows show GBS DNA located in a Lamp1-stained
compartment, whereas white arrows highlight GBS DNA located outside of this compartment.Cell Host & Microbe 4, 543–554, December 11, 2008 ª2008 Elsevier Inc. 551
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Type I IFN Induced by DNA from an Extracellular PathogenTGTCAACTA (forward) and 5-AACCAGCCTGTTTGAGCAGAA (reverse);
HPRT1, 5-CTGGTGAAAAGGACCTCTCG (forward) and 5-TGAAGTACTCATT
ATAGTCAAGGGCA (reverse); TNF-a, 5-CAGTTCTATGGCCCAGACCCT (for-
ward) and 5-CGGACTCCGCAAAGTCTAAG (reverse); IFN-b, 5-ATAAGCAGC
TCCAGCTCCAA (forward) and 5-CTGTCTGCTGGTGGAGTTCA (reverse).
The primers for detection of mouse DAI mRNA has been described elsewhere
(Takaoka et al., 2007).
Cell Extracts and Western Blotting
The nuclear cell extraction method has been described elsewhere (Severa
et al., 2006). The nuclear extracts were stored at 20C before being sepa-
rated by 7.5% SDS-PAGE gel (NuStep; French Forests, Australia) and blotted
onto nitrocellulose membrane (Amersham Bioscience; Bucks, UK). Blots
were incubated with rabbit polyclonal antibody anti-phosphorylated STAT2
(Millipore; Lake Placid, NY), followed by a secondary Ab conjugated with
horseradish peroxidase. The blots were developed with an ECL system
(Amersham Biosciences; Little Chalfont, Bucks, UK).
Cell Infections and Treatments
Macrophages were infected with GBS at a multiplicity of infection (MOI) as
stated. Sendai virus (150 HAU/ml), Cantrell strain was from Charles River
Laboratories (Boston, MA). GBS extract (80 mg/ml) was prepared as previously
described (Stetson and Medzhitov, 2006). The treatments with DNase I
(QIAGEN; Valencia, CA), RNase A (Ambion; Austin, TX), or RNase H (Invitrogen;
Carlsbad, CA) were performed according to the manufacturers instructions.
GBS DNA was delivered to the cell with Lipofectamine 2000 (Invitrogen; Carls-
bad, CA) at a ratio of 3 ml Lipofectamine to 1 mg DNA in OptiMEM (Invitrogen;
Carlsbad, CA).
Electron Microscopy
Macrophages were infected with GBS at a MOI of 10:1 and incubated for 2 hr.
The cells were then washed extensively in PBS before being fixed in a solution
of 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). Cells were then
embedded and sectioned for transmission electron microscopy.
Confocal Microscopy
Confocal reflection microscopy was combined with fluorescence microscopy
on a Leica SP2 AOBS confocal laser scanning microscope. Reflection was
captured by placing the detector channel directly over the wavelength of the
selected laser channel for reflection light capture, and the AOBS was set to
allow 5%–15% of laser light into the collection channel. Fluorescence was
simultaneously captured by standard confocal imaging techniques.
Overexpression and Knock Down of DAI Receptor
To generate the DAI retroviral expression vector, DAI cDNA was excised from
pCAGGS-HA-DAI (a kind gift from T. Taniguchi [University of Tokyo; Tokyo,
Japan]) and cloned into the SalI and NotI sites of GFP expression retrovirus
vector, based on the CLNCX vector (Reeves et al., 1996). The retrovirus encod-
ing for DAI as well as the empty vector were packaged in 293T cells and added
to the target cells 48 hr prior to stimulation, following a previously described
protocol (http://www.broad.mit.edu/genome_bio/trc/publicProtocols.html).
The quality of the infection was assessed using the GFP tag.
The shRNA vectors were purchased from MISSION shRNA clones (Sigma
Aldrich; St. Louis, MO) and used to generate lentiviral transduction particles
in packaging cell lines, following protocols obtained from the RNAi consortium
(http://www.broad.mit.edu/genome_bio/trc/rnai.html). IFN-b was from Bio-
gen, Inc. (Cambridge, MA) and was used to induce upregulation of the DAI
gene to check for the quality of the shRNA.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found online at http://www.
cell.com/cellhostandmicrobe/supplemental/S1931-3128(08)00369-7.
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